Security Snapshot

CorMedix Inc. - Common Stock (CRMD) Institutional Ownership

CUSIP: 21900C308

13F Institutional Holders and Ownership History from Q1 2019 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

199

Shares (Excl. Options)

41,963,760

Price

$11.63

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Common Stock
Symbol
CRMD on Nasdaq
Shares outstanding
79,310,345
Price per share
$6.79
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
41,963,760
Total reported value
$487,971,722
% of total 13F portfolios
0%
Share change
-1,307,769
Value change
-$15,316,010
Number of holders
199
Price from insider filings
$6.79
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Sponsored

Quick Takeaways

  • CRMD - CorMedix Inc. - Common Stock is tracked under CUSIP 21900C308.
  • 199 institutions reported positions in Q4 2025.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 199 to 8 between Q4 2025 and Q1 2026.
  • Reported value moved from $487,971,722 to $347,986.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 199 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 21900C308?
CUSIP 21900C308 identifies CRMD - CorMedix Inc. - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of CorMedix Inc. - Common Stock (CRMD) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Deep Track Capital, LP 6.3% $55,204,125 4,955,487 Deep Track Capital, LP 21 Nov 2025
SHAIBATALHAMD AYMEN ABDALKADER 5.8% -6.7% $44,390,000 -$440,330 4,600,000 -0.98% SHAIBATALHAMD AYMEN ABDALKADER 01 Jan 2026
BlackRock, Inc. 7.5% $41,659,221 4,567,897 BlackRock, Inc. 31 Dec 2024

As of 31 Dec 2025, 199 institutional investors reported holding 41,963,760 shares of CorMedix Inc. - Common Stock (CRMD). This represents 53% of the company’s total 79,310,345 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of CorMedix Inc. - Common Stock (CRMD) together control 40% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 7.3% 5,776,428 +1.5% 0% $67,179,857
Deep Track Capital, LP 6.6% 5,274,076 +955% 1.4% $61,337,504
VANGUARD GROUP INC 5.7% 4,499,010 +13% 0% $52,323,486
MARSHALL WACE, LLP 2.5% 1,966,262 -43% 0.02% $22,867,628
STATE STREET CORP 2.4% 1,920,861 +4.6% 0% $22,339,613
GEODE CAPITAL MANAGEMENT, LLC 2.4% 1,912,233 +5.7% 0% $22,242,743
DEERFIELD MANAGEMENT COMPANY, L.P. 1.4% 1,107,944 -67% 0.17% $12,885,389
Alyeska Investment Group, L.P. 1.1% 850,000 -33% 0.03% $9,885,500
GOLDMAN SACHS GROUP INC 1% 828,781 +259% 0% $9,638,723
OBERWEIS ASSET MANAGEMENT INC/ 1% 805,115 +2.5% 0.34% $9,363,487
KENNEDY CAPITAL MANAGEMENT LLC 0.83% 658,105 -0.08% 0.16% $7,653,761
MORGAN STANLEY 0.82% 648,762 -23% 0% $7,545,108
UBS Group AG 0.8% 636,035 -42% 0% $7,397,088
NORTHERN TRUST CORP 0.77% 614,598 -0.16% 0% $7,147,775
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.77% 610,928 +4.5% 0% $7,105,093
Palisades Investment Partners, LLC 0.73% 576,759 +2.2% 2.5% $6,707,707
RAYMOND JAMES FINANCIAL INC 0.59% 465,441 -29% 0% $5,413,078
Squarepoint Ops LLC 0.54% 432,215 +129% 0.01% $5,026,660
Private Advisor Group, LLC 0.48% 378,537 +39% 0.02% $4,402,391
Bank of New York Mellon Corp 0.48% 376,907 +46% 0% $4,383,429
NEW YORK STATE COMMON RETIREMENT FUND 0.4% 320,997 +7.9% 0% $3,733,195
CITADEL ADVISORS LLC 0.4% 320,150 -81% 0% $3,723,344
VICTORY CAPITAL MANAGEMENT INC 0.4% 314,970 +34% 0% $3,663,101
October Effect Ltd 0.39% 306,444 -27% 3.9% $3,563,944
Assenagon Asset Management S.A. 0.38% 302,508 +35% 0.01% $3,518,168

Institutional Holders of CorMedix Inc. - Common Stock (CRMD) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 50,317 $347,986 -$2,425 $6.79 8
2025 Q4 41,963,760 $487,971,722 -$15,316,010 $11.63 199
2025 Q3 43,121,910 $501,528,237 +$101,799,375 $11.63 189
2025 Q2 34,151,234 $420,699,898 +$142,837,808 $12.32 169
2025 Q1 23,724,937 $146,235,596 +$397,499 $6.16 135
2024 Q4 22,893,836 $185,441,545 +$29,955,443 $8.10 126
2024 Q3 19,135,638 $154,655,147 +$21,831,393 $8.08 100
2024 Q2 17,129,390 $74,162,669 -$748,246 $4.33 97
2024 Q1 17,269,642 $73,216,929 -$5,693,027 $4.24 89
2023 Q4 18,742,007 $70,461,032 +$3,045,526 $3.76 101
2023 Q3 17,891,223 $66,197,207 -$5,485,628 $3.70 92
2023 Q2 19,187,043 $76,065,204 +$33,053,416 $3.96 86
2023 Q1 10,770,110 $44,582,136 -$1,863,278 $4.14 64
2022 Q4 11,182,776 $47,050,210 +$1,816,100 $4.22 62
2022 Q3 10,928,271 $31,131,890 -$4,497,215 $2.83 66
2022 Q2 12,425,504 $49,348,797 -$5,601,808 $4.02 69
2022 Q1 13,362,668 $73,354,516 +$1,886,576 $5.48 83
2021 Q4 13,046,114 $59,435,463 +$5,549,733 $4.55 78
2021 Q3 11,793,247 $54,910,109 +$1,590,384 $4.65 75
2021 Q2 11,351,356 $77,873,368 +$3,221,689 $6.86 77
2021 Q1 10,781,064 $107,630,096 +$16,345,897 $9.99 76
2020 Q4 9,261,298 $68,791,909 +$7,239,796 $7.43 74
2020 Q3 8,327,514 $50,205,664 +$9,581,252 $6.03 70
2020 Q2 6,739,459 $42,456,689 +$1,328,313 $6.30 67
2020 Q1 6,612,416 $23,732,293 -$6,155,816 $3.59 57
2019 Q4 6,440,146 $46,873,565 +$176,523 $7.28 62
2019 Q3 6,472,987 $41,291,108 +$6,489,686 $6.38 55
2019 Q2 5,421,031 $48,610,180 +$15,505,635 $8.97 45
2019 Q1 3,663,429 $34,616,000 +$34,616,000 $9.45 37

Sponsored